Search - tctmd.com

Displaying 241 - 260 of 304

Sort: Relevancy | Date

News Daily News

It Takes a Village: Diverse Gut Microbes Linked to Arterial Health in Women

Caitlin E. Cox

May 15, 2018

News Conference News SCAI 2018

Coronary Plaques in Psoriasis Patients Change After Treatment With Biologics

L.A. McKeown

May 01, 2018

News Daily News

New Biomarker on the Block, FGF-23, May Aid in Secondary-Event Prediction Following ACS

Yael L. Maxwell

April 18, 2018

News Conference News ACC 2018

High CRP Linked to Bigger Absolute Drops in CV Events for Patients Taking Evolocumab

Michael O'Riordan

March 20, 2018

News Conference News ACC 2018

Canakinumab Falls Short of Halting Progression to Diabetes in Patients at Risk: CANTOS

Michael O'Riordan

March 12, 2018

News Conference News ACC 2018

Inflammatory Bowel Disease May Up the Risk of MI, Especially in Young People

L.A. McKeown

March 09, 2018

News Conference News CRT 2018

Acute MI Patients With Paraplegia Rarely Get Revascularization, Face Higher Risk of Death

Shelley Wood

March 05, 2018

News Daily News

Genetic Tendency Toward Depression Signals a Higher Ischemic Stroke Risk

Todd Neale

February 14, 2018

News Daily News

Beyond LDL Cholesterol: Lipoprotein Particles Linked With MI and Ischemic Stroke

Michael O'Riordan

February 07, 2018

News Daily News

Sixfold Higher Risk of Acute MI in the Week After Flu Diagnosis

Michael O'Riordan

January 24, 2018

News Daily News

Surviving CVD: Obesity Offers No Protection for Those With New Onset Cardiac Events

Michael O'Riordan

December 07, 2017

Presentation Controversies and Advances 2017

Targeting Inflammation in Atherosclerosis: Has CANTOS Nailed It?

Presenter: Sanjay Kaul

November 16, 2017

News Conference News AHA 2017

Sustained Blood Pressure Reductions With Gastric Bypass Surgery: GATEWAY

Michael O'Riordan

November 16, 2017

News Conference News AHA 2017

CANTOS: Big Drop in CVD Events Among Canakinumab Responders

Michael O'Riordan

November 13, 2017

News Daily News

Colchicine Stabilizes Plaque in ACS Patients, Imaging Study Suggests

Michael O'Riordan

October 20, 2017

News Daily News

Atrial Fibrillation in Obese Patients a Growing Concern, Experts Say

Caitlin E. Cox

October 10, 2017

News Daily News

Another Study Challenges Notion of ‘Healthy Obese’

L.A. McKeown

September 11, 2017

News Conference News ESC 2017

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

Michael O'Riordan

August 27, 2017

News Daily News

Air Pollution Tightly Tied to CV Disease, Chinese Study Confirms

Ashley Lyles

August 15, 2017

News Daily News

ADAPT-DES at 2 Years Offers Insights Into Provider Strategies and Aspirin Monotherapy Beyond 1 Year

Yael L. Maxwell

August 07, 2017

Advertisement

It Takes a Village: Diverse Gut Microbes Linked to Arterial Health in Women

Coronary Plaques in Psoriasis Patients Change After Treatment With Biologics

New Biomarker on the Block, FGF-23, May Aid in Secondary-Event Prediction Following ACS

High CRP Linked to Bigger Absolute Drops in CV Events for Patients Taking Evolocumab

Canakinumab Falls Short of Halting Progression to Diabetes in Patients at Risk: CANTOS

Inflammatory Bowel Disease May Up the Risk of MI, Especially in Young People

Acute MI Patients With Paraplegia Rarely Get Revascularization, Face Higher Risk of Death

Genetic Tendency Toward Depression Signals a Higher Ischemic Stroke Risk

Beyond LDL Cholesterol: Lipoprotein Particles Linked With MI and Ischemic Stroke

Sixfold Higher Risk of Acute MI in the Week After Flu Diagnosis

Surviving CVD: Obesity Offers No Protection for Those With New Onset Cardiac Events

Targeting Inflammation in Atherosclerosis: Has CANTOS Nailed It?

Sustained Blood Pressure Reductions With Gastric Bypass Surgery: GATEWAY

CANTOS: Big Drop in CVD Events Among Canakinumab Responders

Colchicine Stabilizes Plaque in ACS Patients, Imaging Study Suggests

Atrial Fibrillation in Obese Patients a Growing Concern, Experts Say

Another Study Challenges Notion of ‘Healthy Obese’

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

Air Pollution Tightly Tied to CV Disease, Chinese Study Confirms

ADAPT-DES at 2 Years Offers Insights Into Provider Strategies and Aspirin Monotherapy Beyond 1 Year

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content